Antimicrobial activity of imidazo[1,5-a]quinoxaline derivatives with pyridinium moiety

被引:52
作者
Kalinin, Alexey A. [1 ]
Voloshina, Alexandra D. [1 ]
Kulik, Nataliya V. [1 ]
Zobov, Vladimir V. [1 ,2 ]
Mamedov, Vakhid A. [1 ]
机构
[1] Russian Acad Sci, AE Arbuzov Inst Organ & Phys Chem, Kazan 420088, Russia
[2] Kazan VI Lenin State Univ, Kazan 420008, Russia
基金
俄罗斯基础研究基金会;
关键词
Imidazo[1,5-a]quinoxalines; Pyridinium salt; Bacteriostatic activity; Fungistatic activity; HIGH-AFFINITY; BENZODIAZEPINE-RECEPTOR; QUINOXALINE DERIVATIVES; PARTIAL AGONIST; ANALOGS; POTENT; UREAS; INHIBITOR; COMPLEX; AMIDES;
D O I
10.1016/j.ejmech.2013.05.038
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
3-Phenyl(methyl)-5-alkyl-1-(pyridin-3-yl)imidazo[1,5-a]quinoxalin-4-ones (2a-f) and their N-alkylpyridinium salts (3a-o), including 1,n-bis{3-(3-phenylimidazo[1,5-a]quinoxalin-4(5H)-on-1-yl)pyridinium}alkane dibromides (4a-d, 5, 6) have been synthesized. It has been established that the antimicrobial properties of imidazo[1,5-a]quinoxaline derivatives are connected with the presence of various alkyl substituents in the position 1 of the pyridine ring and in the position 5 of the imidazo[1,5-a]quinoxaline system. Chlorides and iodides are more active towards bacteria than fungi. Compounds 3d, 3e, 3m and 3n showed an effective bacteriostatic activity. Compound showed not only well defined bacteriostatic activities but also good fungistatic activities, with the MIC values comparable with the reference drugs. Toxicity of more effective (imidazo[1,5-a]quinoxalin-4-on-1-yl)-1-pyridinium halides was examined in mice. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:345 / 354
页数:10
相关论文
共 29 条
[1]   Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents [J].
Abu-Hashem, A. A. ;
Gouda, M. A. ;
Badria, F. A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (05) :1976-1981
[2]  
[Anonymous], 1993, [No title captured], Patent No. [WO 9317025, 9317025, WO 9317025 PCT]
[3]  
[Anonymous], 1990, EP P., Patent No. [EP 400583, 400583]
[4]  
[Anonymous], 1992, [No title captured], Patent No. [WO 9207853, 9207853, WO 9207853 PCT]
[5]  
[Anonymous], 1991, [No title captured], Patent No. [WO 9107407, 9107407]
[6]   Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805 [J].
Baffert, Fabienne ;
Regnier, Catherine H. ;
De Pover, Alain ;
Pissot-Soldermann, Carole ;
Tavares, Gisele A. ;
Blasco, Francesca ;
Brueggen, Josef ;
Chene, Patrick ;
Drueckes, Peter ;
Erdmann, Dirk ;
Furet, Pascal ;
Gerspacher, Marc ;
Lang, Marc ;
Ledieu, David ;
Nolan, Lynda ;
Ruetz, Stephan ;
Trappe, Joerg ;
Vangrevelinghe, Eric ;
Wartmann, Markus ;
Wyder, Lorenza ;
Hofmann, Francesco ;
Radimerski, Thomas .
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (07) :1945-1955
[7]  
Biotie/Wyeth, 2010, [No title captured], Patent No. [WO2010138833, 2010138833, 2010/ 138833]
[8]  
Brooks H.L., 1989, AGR HDB, VIV
[9]   NOVEL COMPOUNDS POSSESSING POTENT CAMP AND CGMP PHOSPHODIESTERASE INHIBITORY ACTIVITY - SYNTHESIS AND CARDIOVASCULAR EFFECTS OF A SERIES OF IMIDAZO[1,2-A]QUINOXALINONES AND IMIDAZO[1,5-A]QUINOXALINONES AND THEIR AZA ANALOGS [J].
DAVEY, DD ;
ERHARDT, PW ;
CANTOR, EH ;
GREENBERG, SS ;
INGEBRETSEN, WR ;
WIGGINS, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (09) :2671-2677
[10]   Synthesis of cyclopeptidic analogues of triostin A with quinoxalines or nucleobases as chromophores [J].
Dietrich, B ;
Diederichsen, U .
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2005, 2005 (01) :147-153